Bret Jensen
Contributor since: 2010
Company: The Biotech Forum
Articles
The Verdict On Actinium Pharmaceuticals
Yesterday, 2:58 PM ATNM7 Comments
Our First Peek At Passage Bio
Thu, Mar. 4 PASG4 Comments
Circling Back On OncoCyte Stock
Thu, Mar. 4 OCX1 Comment
Our First Look At Fulcrum Therapeutics
Thu, Mar. 4 FULC1 Comment
Circling Back On NuCana Stock
Wed, Mar. 3 NCNA1 Comment
Sizing Up Spectrum Pharmaceuticals
Wed, Mar. 3 SPPI3 Comments
Circling Back On Axsome Therapeutics
Tue, Mar. 2 AXSM9 Comments
Fathoming The FDA Decision On FibroGen
Tue, Mar. 2 FGEN2 Comments
The Outlook For Athersys Stock
Tue, Mar. 2 ATHX23 Comments
Dynavax Technologies: A Surprising COVID-19 Play
Mon, Mar. 1 DVAX20 Comments
Celsion: Still Waiting For Godot
Mon, Mar. 1 CLSN12 Comments
Supernus Pharmaceuticals: Solid Quarter, Solid Stock
Sun, Feb. 28 SUPN4 Comments
Checking Back On Kadmon Holdings
Thu, Feb. 25 KDMN5 Comments
CTI BioPharma: Potential Light At End Of The Rainbow
Thu, Feb. 25 CTIC2 Comments
Going Under The Covers With Surface Oncology
Mon, Feb. 22 SURF6 Comments
Circling Back On Clearside Biomedical
Mon, Feb. 22 CLSD5 Comments
Vectoring In On Viking Therapeutics
Sat, Feb. 20 VKTX9 Comments
Wave Life Sciences: Hanging Around $10
Fri, Feb. 19 WVE12 Comments
Our First Look At Protara Therapeutics
Fri, Feb. 19 TARA2 Comments
CymaBay Therapeutics: Checking In On This Roller Coaster Stock
Wed, Feb. 17 CBAY3 Comments
Revisiting Reata Pharmaceuticals Again
Tue, Feb. 16 RETA11 Comments
Revisiting Recro Pharma
Mon, Feb. 15 REPH6 Comments
The Latest On Xeris Pharmaceuticals
Mon, Feb. 15 XERS3 Comments
Reassessing Epizyme
Sun, Feb. 14 EPZM9 Comments
The Verdict On Venus Concept
Thu, Feb. 11 VERO4 Comments
Zogenix: Our Current Take On This 'Battleground' Biopharma Stock
Wed, Feb. 10 ZGNX5 Comments
The Right Call On Cara Therapeutics
Tue, Feb. 9 CARA10 Comments
Heron Therapeutics: A Name That Could Gain Traction In 2021
Mon, Feb. 8 HRTX6 Comments
Beyond Air: A Name To Keep An Eye On
Sat, Feb. 6 XAIR7 Comments
Taking Another Gander At Greif
Fri, Feb. 5 GEF3 Comments
Revisiting Radius Health
Mon, Feb. 1 RDUS10 Comments
Assessing Aurinia Pharmaceuticals Post FDA Approval
Fri, Jan. 29 AUPH53 Comments